In this study, we compared the difference in cellular responses by pKAL between p53-wild and p53-null HCT116 human colorectal cancer cells to investigate an influence of endogenous p53 on pKAL-induced anticancer effects. The gene discussed is TP53; the disease is colorectal cancer.